Lack of pharmacokinetic interaction between retigabine and phenobarbitone at steady-state in healthy subjects

AIMS: To evaluate potential pharmacokinetic interactions between phenobarbitone and retigabine, a new antiepileptic drug. METHODS: Fifteen healthy men received 200 mg of retigabine on day 1. On days 4–32, phenobarbitone 90 mg was administered at 22.00 h. On days 26–32, increasing doses of retigabine...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Ferron, Geraldine M, Patat, Alain, Parks, Virginia, Rolan, Paul, Troy, Steven M
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Blackwell Science Inc 2003
Aiheet:
Pharmacokinetics
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC1884339/
https://ncbi.nlm.nih.gov/pubmed/12848774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2125.2003.01825.x
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia